vs

Side-by-side financial comparison of Dayforce (DAY) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

Dayforce is the larger business by last-quarter revenue ($481.6M vs $243.8M, roughly 2.0× Harmony Biosciences Holdings, Inc.). Harmony Biosciences Holdings, Inc. runs the higher net margin — 9.2% vs -40.9%, a 50.1% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs 9.5%). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs 9.8%).

Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

DAY vs HRMY — Head-to-Head

Bigger by revenue
DAY
DAY
2.0× larger
DAY
$481.6M
$243.8M
HRMY
Growing faster (revenue YoY)
HRMY
HRMY
+11.7% gap
HRMY
21.1%
9.5%
DAY
Higher net margin
HRMY
HRMY
50.1% more per $
HRMY
9.2%
-40.9%
DAY
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
9.8%
DAY

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DAY
DAY
HRMY
HRMY
Revenue
$481.6M
$243.8M
Net Profit
$-196.8M
$22.5M
Gross Margin
71.9%
Operating Margin
6.3%
15.8%
Net Margin
-40.9%
9.2%
Revenue YoY
9.5%
21.1%
Net Profit YoY
-9940.0%
-54.6%
EPS (diluted)
$-1.23
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAY
DAY
HRMY
HRMY
Q4 25
$243.8M
Q3 25
$481.6M
$239.5M
Q2 25
$464.7M
$200.5M
Q1 25
$481.8M
$184.7M
Q4 24
$465.2M
$201.3M
Q3 24
$440.0M
$186.0M
Q2 24
$423.3M
$172.8M
Q1 24
$431.5M
$154.6M
Net Profit
DAY
DAY
HRMY
HRMY
Q4 25
$22.5M
Q3 25
$-196.8M
$50.9M
Q2 25
$21.3M
$39.8M
Q1 25
$14.9M
$45.6M
Q4 24
$10.8M
$49.5M
Q3 24
$2.0M
$46.1M
Q2 24
$-1.8M
$11.6M
Q1 24
$7.1M
$38.3M
Gross Margin
DAY
DAY
HRMY
HRMY
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
47.0%
73.0%
Q3 24
45.8%
77.0%
Q2 24
44.1%
81.4%
Q1 24
47.6%
82.2%
Operating Margin
DAY
DAY
HRMY
HRMY
Q4 25
15.8%
Q3 25
6.3%
27.3%
Q2 25
9.1%
24.0%
Q1 25
6.4%
30.4%
Q4 24
6.1%
27.7%
Q3 24
4.7%
33.2%
Q2 24
3.3%
12.4%
Q1 24
9.4%
33.7%
Net Margin
DAY
DAY
HRMY
HRMY
Q4 25
9.2%
Q3 25
-40.9%
21.2%
Q2 25
4.6%
19.8%
Q1 25
3.1%
24.7%
Q4 24
2.3%
24.6%
Q3 24
0.5%
24.8%
Q2 24
-0.4%
6.7%
Q1 24
1.6%
24.8%
EPS (diluted)
DAY
DAY
HRMY
HRMY
Q4 25
$0.38
Q3 25
$-1.23
$0.87
Q2 25
$0.13
$0.68
Q1 25
$0.09
$0.78
Q4 24
$0.07
$0.85
Q3 24
$0.01
$0.79
Q2 24
$-0.01
$0.20
Q1 24
$0.04
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAY
DAY
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$627.6M
$775.3M
Total DebtLower is stronger
$631.1M
$163.7M
Stockholders' EquityBook value
$2.7B
$870.2M
Total Assets
$8.7B
$1.3B
Debt / EquityLower = less leverage
0.23×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAY
DAY
HRMY
HRMY
Q4 25
$775.3M
Q3 25
$627.6M
$672.6M
Q2 25
$625.2M
$565.3M
Q1 25
$557.3M
$507.0M
Q4 24
$579.7M
$467.2M
Q3 24
$494.1M
$410.5M
Q2 24
$465.4M
$346.9M
Q1 24
$392.5M
$372.4M
Total Debt
DAY
DAY
HRMY
HRMY
Q4 25
$163.7M
Q3 25
$631.1M
$168.5M
Q2 25
$631.8M
$172.1M
Q1 25
$632.4M
$175.7M
Q4 24
$1.2B
$179.3M
Q3 24
$1.2B
$182.8M
Q2 24
$1.2B
$186.4M
Q1 24
$1.2B
$190.0M
Stockholders' Equity
DAY
DAY
HRMY
HRMY
Q4 25
$870.2M
Q3 25
$2.7B
$835.1M
Q2 25
$2.7B
$773.1M
Q1 25
$2.6B
$720.5M
Q4 24
$2.5B
$659.2M
Q3 24
$2.6B
$596.8M
Q2 24
$2.5B
$538.6M
Q1 24
$2.4B
$515.4M
Total Assets
DAY
DAY
HRMY
HRMY
Q4 25
$1.3B
Q3 25
$8.7B
$1.2B
Q2 25
$8.5B
$1.1B
Q1 25
$9.5B
$1.1B
Q4 24
$9.1B
$999.2M
Q3 24
$8.1B
$928.1M
Q2 24
$9.0B
$858.4M
Q1 24
$10.8B
$847.0M
Debt / Equity
DAY
DAY
HRMY
HRMY
Q4 25
0.19×
Q3 25
0.23×
0.20×
Q2 25
0.23×
0.22×
Q1 25
0.24×
0.24×
Q4 24
0.47×
0.27×
Q3 24
0.47×
0.31×
Q2 24
0.49×
0.35×
Q1 24
0.50×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAY
DAY
HRMY
HRMY
Operating Cash FlowLast quarter
$31.2M
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAY
DAY
HRMY
HRMY
Q4 25
$126.2M
Q3 25
$31.2M
$108.7M
Q2 25
$112.7M
$79.3M
Q1 25
$49.6M
$34.0M
Q4 24
$81.0M
$75.6M
Q3 24
$91.8M
$70.5M
Q2 24
$99.2M
$42.6M
Q1 24
$9.1M
$31.1M
Free Cash Flow
DAY
DAY
HRMY
HRMY
Q4 25
$126.0M
Q3 25
$108.7M
Q2 25
$79.3M
Q1 25
$33.9M
Q4 24
$75.0M
Q3 24
$70.5M
Q2 24
$42.0M
Q1 24
$31.1M
FCF Margin
DAY
DAY
HRMY
HRMY
Q4 25
51.7%
Q3 25
45.4%
Q2 25
39.6%
Q1 25
18.3%
Q4 24
37.3%
Q3 24
37.9%
Q2 24
24.3%
Q1 24
20.1%
Capex Intensity
DAY
DAY
HRMY
HRMY
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
0.4%
Q1 24
0.0%
Cash Conversion
DAY
DAY
HRMY
HRMY
Q4 25
5.61×
Q3 25
2.14×
Q2 25
5.29×
1.99×
Q1 25
3.33×
0.75×
Q4 24
7.50×
1.53×
Q3 24
45.90×
1.53×
Q2 24
3.68×
Q1 24
1.28×
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAY
DAY

Dayforce Recurring$333.0M69%
Cloud And Bureau Professional Services And Other$78.5M16%
Float$42.2M9%
Powerpay Recurring$19.7M4%
Other Recurring$8.2M2%

HRMY
HRMY

Segment breakdown not available.

Related Comparisons